CollPlant Biotechnologies Ltd.

NASDAQ: CLGN
Share price (8/22/25): $2.52
Market cap (8/22/25): $28.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Updated info for already-effective prospectus

Prospectus supplement

Initial registration of new securities for foreign issuers

Exempt offering of securities

Prospectus supplement for primary offering

Ownership Filter

Loewenbaum Lilian S.

Roumell Asset Management, LLC

Loewenbaum Lilian S.

News Filter

Reports 2025 Second Quarter Financial Results and Provides Corporate Update

Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations New U.S.-based Role to Support Growth Strategy, Partnerships, and Scaling of rhCollagen Product Platforms

Broadens Its Collaboration With Stemcell Technologies

Announces European Patent Allowance Secured for Its Collagen-Based Formulations Usable as Soft Tissue Fillers and Implants

Material disclosure

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC